Madison Square Garden Sports' Return to Profitability Hinges on What Management Won't Say on a Call
Madison Square Garden Sports Corp. (MSGS) reports fiscal third quarter 2026 earnings on May 8, 2026, before market open, with analysts expecting $0.66 per share on the strength of the Knicks' and Rangers' playoff runs and the NBA's new national media rights deal. The central question: can the company sustain the momentum from its fiscal second quarter—when all in-game revenue categories grew on a per-game basis—while navigating the structural headwind of reduced local media rights fees? With the stock up 29% over the past six months and trading near all-time highs, investors will scrutinize whether the underlying business fundamentals justify the valuation or whether the rally has priced in too much optimism.
Part 1: Earnings Preview
Madison Square Garden Sports Corp. owns and operates two of the most iconic franchises in professional sports: the New York Knicks (NBA) and the New York Rangers (NHL), along with their respective development league teams and the MSG Training Center. The company generates revenue from ticket sales, suites, sponsorships, food and beverage, merchandise, and media rights—making it a pure-play bet on the enduring value of marquee sports franchises in the world's largest media market.
For the fiscal third quarter ending March 31, 2026, analysts expect MSGS to report $0.66 per share, a dramatic turnaround from the $0.34 per share reported in the most recent quarter (Q2 fiscal 2026). Year-over-year, the estimate represents a +211.86% improvement versus the -$0.59 loss posted in the same quarter last year, when the company took charges related to team personnel transactions and faced the initial impact of amended local media rights agreements.
Three key themes define this earnings story:
1. NBA National Media Rights Uplift: The NBA's new national media rights agreements—which began with the 2025-26 season—delivered an $18.6 million revenue increase in Q2 from league distributions alone. This structural tailwind is expected to continue benefiting results, though investors will watch whether the uplift is being offset by rising player compensation and luxury tax obligations.
2. Local Media Rights Headwind: Amendments to the Knicks' and Rangers' local media rights agreements with MSG Networks resulted in a $21.9 million revenue decline in Q2. This is the most significant structural risk to the investment thesis, as local media income has become "reduced and less predictable," according to analyst commentary. The question is whether in-game revenue growth can fully compensate for this permanent reset.
3. In-Game Revenue Momentum Across All Categories: The fiscal second quarter saw increases in every in-game revenue line—ticketing, suites, sponsorship, and food/beverage/merchandise—on a per-game basis. With robust consumer and corporate demand, the company is demonstrating pricing power and operational execution. Investors will look for confirmation that this momentum carried into Q3, particularly with both teams in playoff contention.
Analysts heading into the release have emphasized the "positive momentum in key operating areas" and the company's ability to drive long-term shareholder value despite media headwinds. The board's February 2026 decision to explore spinning off the Knicks and Rangers into separate public companies adds a strategic catalyst, though no update on the process is expected in this release. The consensus view is that the iconic franchise value and in-venue revenue strength can outweigh the structural pressure on local media rights—but execution in Q3 will be critical to validating that thesis.
Part 2: Historical Earnings Performance
Madison Square Garden Sports has delivered a mixed earnings track record over the past four quarters, with two beats and two misses—but the misses have been far more severe than the beats. In Q3 fiscal 2025 (March 2025), the company posted a -$0.59 loss versus a $1.48 estimate, a stunning -139.86% miss driven by team personnel transaction charges and the initial impact of amended local media agreements. The following quarter (Q4 fiscal 2025, June 2025) saw a +83.33% beat as the company reported -$0.07 versus a -$0.42 estimate, benefiting from better-than-expected cost management. Q1 fiscal 2026 (September 2025) delivered another +64.42% beat with -$0.37 versus a -$1.04 estimate, as the company began to demonstrate operational momentum. Most recently, Q2 fiscal 2026 (December 2025) resulted in a -48.48% miss, reporting $0.34 versus a $0.66 estimate, despite strong revenue growth across all in-game categories.
The pattern reveals significant earnings volatility tied to one-time charges, roster decisions, and the timing of media rights adjustments. When the company beats, it tends to do so by managing costs better than expected; when it misses, the shortfalls are dramatic and often tied to non-recurring items or structural changes in the business model. The most recent quarter's miss—despite strong operational performance—suggests that analysts may still be underestimating the impact of rising player compensation and luxury tax obligations, which increased $13.0 million year-over-year in Q2. Heading into Q3, investors should be cautious about taking the consensus estimate at face value, given the company's tendency to surprise in both directions by wide margins.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $1.48 | $-0.59 | -139.86% | Miss |
| Jun 2025 | $-0.42 | $-0.07 | +83.33% | Beat |
| Sep 2025 | $-1.04 | $-0.37 | +64.42% | Beat |
| Dec 2025 | $0.66 | $0.34 | -48.48% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Madison Square Garden Sports typically reports earnings before market open, meaning Day 0 represents the first full trading session where the market can react to results, and Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-05 | -$13.60 (-4.73%) | $33.41 (11.63%) | +$5.64 (+2.06%) | $6.07 (2.22%) |
| 2025-10-31 | -$10.38 (-4.62%) | $10.79 (4.80%) | +$2.54 (+1.18%) | $11.83 (5.52%) |
| 2025-08-12 | -$7.08 (-3.50%) | $11.31 (5.59%) | -$0.88 (-0.45%) | $6.91 (3.54%) |
| 2025-05-02 | -$5.49 (-2.85%) | $7.96 (4.12%) | +$1.51 (+0.81%) | $4.98 (2.66%) |
| 2025-02-04 | -$7.83 (-3.59%) | $10.22 (4.68%) | -$1.58 (-0.75%) | $4.26 (2.02%) |
| 2024-11-01 | -$1.71 (-0.77%) | $12.24 (5.50%) | -$5.11 (-2.31%) | $7.41 (3.35%) |
| 2024-08-13 | -$1.02 (-0.52%) | $19.27 (9.84%) | +$2.09 (+1.07%) | $2.69 (1.38%) |
| 2024-05-02 | -$2.45 (-1.32%) | $4.24 (2.28%) | +$1.34 (+0.73%) | $8.86 (4.83%) |
| Avg Abs Move | 2.74% | 6.06% | 1.17% | 3.19% |
Historically, MSGS has exhibited moderate post-earnings volatility, with an average absolute Day 0 move of 2.74% and an average Day 0 range of 6.06%—indicating that the stock tends to gap and then trade in a relatively wide intraday band as investors digest the results. Day +1 follow-through has been more muted, averaging 1.17% with a 3.19% range, suggesting that the initial reaction tends to hold rather than reverse sharply.
The most recent earnings release (February 2026) saw a -4.73% Day 0 decline on an 11.63% intraday range—the widest swing in the dataset—followed by a +2.06% Day +1 recovery, indicating that the initial selloff was partially reversed as investors absorbed the strong revenue growth narrative. The October 2025 release produced a similar pattern: a -4.62% Day 0 drop followed by a +1.18% Day +1 bounce. In contrast, the May 2025 and August 2025 releases saw smaller Day 0 moves (-2.85% and -3.50%, respectively) with modest positive follow-through.
The data suggests that MSGS tends to sell off on earnings day regardless of the fundamental outcome, likely reflecting profit-taking after run-ups into the release or disappointment over near-term guidance. However, the stock has shown a tendency to recover some of those losses the following session, particularly when the underlying revenue trends are strong. Investors should be prepared for a 3–5% initial move in either direction, with the potential for a reversal if the market's initial reaction appears overdone.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 8) |
| Expected Move | $18.62 (5.62%) |
| Expected Range | $312.44 to $349.67 |
| Implied Volatility | 51.64% |
The options market is pricing an expected move of ±5.62% (±$18.62) through the May 15 expiration, which is more than double the stock's average historical Day 0 move of 2.74% but slightly below the 6.06% average Day 0 range. This suggests that options traders are anticipating above-average volatility for this release, likely reflecting uncertainty around the sustainability of in-game revenue growth and the potential for guidance commentary on the Knicks/Rangers spin-off exploration.
Part 3: What Analysts Are Saying
Analysts maintain a cautiously optimistic stance on Madison Square Garden Sports, with a consensus rating of 3.89 out of 5.0 (between Hold and Buy) and an average price target of $378.17—implying 13.7% upside from the current price of $332.52. The rating breakdown shows 4 Strong Buys, 0 Moderate Buys, 5 Holds, 0 Moderate Sells, and 0 Strong Sells across 9 covering analysts, reflecting a split between bulls who see the iconic franchise value as underappreciated and more cautious voices concerned about structural media headwinds.
Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 3.89. This stability suggests that analysts are in a "wait-and-see" mode heading into the Q3 release, looking for confirmation that the in-game revenue momentum from Q2 can offset the permanent reset in local media rights fees. The wide target range—from a low of $295.00 to a high of $430.00—underscores the divergence in views on how to value the company in a world where local media income is structurally weaker but national media rights and in-venue revenue are growing.
The consensus target of $378.17 implies that analysts believe the stock has room to run if management can demonstrate that the business model is adapting successfully to the new media landscape. However, the fact that 5 of 9 analysts rate the stock a Hold suggests that many are waiting for more evidence before upgrading their stance. The upcoming earnings release will be a critical test: a strong Q3 print with positive commentary on the spin-off exploration could push more analysts into the Buy camp, while any signs of weakening in-game revenue or rising cost pressures could prompt downgrades.
Part 4: Technical Picture
The Barchart Technical Opinion for MSGS currently stands at 88% Buy, down from 100% Buy one week ago and 100% Buy one month ago, indicating that the technical picture has softened slightly as the stock has pulled back from recent highs. Despite the modest deterioration, the signal remains firmly in bullish territory, reflecting the stock's strong longer-term uptrend.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal suggests near-term momentum has cooled after the recent rally, with the stock consolidating just below its 5-day and 10-day moving averages.
- Medium-term (100% Buy): Strong buy signal indicates that the intermediate-term trend remains firmly positive, supported by the stock's position well above its 50-day and 100-day moving averages.
- Long-term (100% Buy): Strong buy signal reflects the stock's powerful longer-term uptrend, with the 200-day moving average at $257.08 providing a floor nearly 30% below the current price.
Trend Characteristics: The overall trend is characterized as Strong but Weakening, suggesting that while the longer-term uptrend remains intact, near-term momentum has stalled as the stock digests recent gains heading into the earnings release.
The stock is currently trading at $332.52, below its 5-day ($337.30), 10-day ($336.04), and 20-day ($335.01) moving averages, indicating a short-term pullback from the recent peak. However, it remains above its 50-day ($324.77), 100-day ($300.60), and 200-day ($257.08) moving averages, confirming that the broader uptrend is still in place.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $337.30 | 50-Day MA | $324.77 |
| 10-Day MA | $336.04 | 100-Day MA | $300.60 |
| 20-Day MA | $335.01 | 200-Day MA | $257.08 |
The technical setup heading into earnings is supportive but not euphoric—the stock has pulled back modestly from recent highs, which could provide a more favorable risk/reward entry point if results exceed expectations. The fact that MSGS is trading just below its short-term moving averages suggests that some of the pre-earnings momentum has been taken off the table, reducing the risk of a sharp profit-taking selloff if the company delivers in line with estimates. However, the stock's position well above its longer-term moving averages means that any significant disappointment could trigger a deeper correction toward the 50-day moving average at $324.77 or even the 100-day at $300.60. Overall, the technical picture suggests that the market is positioned for a modest beat or in-line result—a strong upside surprise could propel the stock back toward the $350 level, while a miss could see it test support in the $315–$320 range.